We tested the hypothesis that nitric oxide (NO) plays a role in CBF autoregulation in the brain stem during hypotension, In anesthetized rats, local CBF to the brain stem was determined with laser-Doppler flowmetry, and diameters of the basilar artery and its branches were measured through an open cranial window during stepwise hemorrhagic hypoten sion, During topical application of 10-5 moUL and 10-4 moUL N'" -nitro-L-arginine (L-NNA), a nonselective inhibitor of nitric oxide synthase (NOS), CBF started to decrease at higher steps of mean arterial blood pressure in proportion to the concentra tion of L-NNA in stepwise hypotension (45 to 60 mm Hg in the 10-5 moUL and 6b to 75 mm Hg in the 10-4 moUL L-NNA group versus 30 to 45 mm Hg in the control group), Dilator response of the basilar artery to severe hypotension was sig-Abbreviations used: ANOV A, analysis of variance; L-NNA, N"' nitro-L-arginine; MABP, mean arterial blood pressure; NO, nitric ox ide; NOS, nitric oxide synthase; 7-NI, 7-nitro indazole.
Autoregulation of CBF is an intrinsic ability to main tain constant CBF despite blood pressure changes. Pial arterioles have been regarded as the primary sites of autoregulatory function by changing their calibers in re sponse to increase or decrease in blood pressure (Kontos et aI., 1978a; MacKenzie et aI, 1979) , whereas the role of the larger cerebral arteries in CBF autoregulation has been poorly understood. We have recently shown that large arteries, such as the basilar artery, also contribute to reductions in cerebrovascular resistance around the lower limits of CBF autoregulation, and thereby maintain CBF to the brain stem during severe hypotension (Toyoda et aI., 1996) . However, in the study, the mecha nism for dilatation of the basilar artery and its branches during hypotension remained undetermined.
Nitric oxide (NO) or a closely related compound was initially identified as the endothelium-derived relaxing factor (Ignarro et aI., 1987; Palmer et aI., 1987) , and now is also shown to be produced by neurons and glia (Bredt et aI., 1990; Knowles et aI., 1989) . Several studies indi cated that NO modulates both basal cerebral vessel tone and vascular responses under specific pathophysiological circumstances like hypercapnia (Faraci, 1990; Wang et aI., 1992a; Buchanan and Phillis, 1993; Pelligrino et aI., 1993) . In contrast, several conflicting results have been reported regarding the role of NO in CBF autoregulation (Wang et aI., 1992b; Buchanan and Phillis, 1993; Tanaka et aI., 1993; Kelly et aI., 1994; Kobari et aI., 1994; Ta kahashi et a1., 1995) .
The first goal of this study was to examine the hy pothesis that NO regulates CBF autoregulation in the the brain stem as well as autoregulatory responses of differ ent-sized vessels during hypotension. For this purpose, we used an open cranial window to measure local CBF and vessel diameters of the brain stem simultaneously in the presence and absence of N" -nitro-L-arginine (L NNA), a nonselective inhibitor of nitric oxide synthase (NOS) .
Recently, 7-nitro indazole (7-NI) was found to be a relatively selective inhibitor of neuronal NOS (Babbedge et aI., 1993; Moore et aI., 1993) . This compound pro duces potent inhibition of rat cerebellar NOS with an ICso of 0.9 ± 0.1 f.1mo11L (mean ± SEM) (Babbedge et aI., 1993) . Using this compound and other nonselective NOS inhibitors, we can differentiate the origin of NO involved in the CBF autoregulation. Thus, the second goal of this study was to determine, by using 7-NI, whether en<,lothelial NO or neuronal NO is primarily re sponsible for autoregulatory adjustments.
METHODS

Animal preparation
Experiments were performed on 43 male Sprague-Dawley rats, weighing 300 to 450 g. Rats were anesthetized with amo barbital sodium, an initial dose of 50 mg/kg intraperitoneally, and followed by additional doses of 15 to 20 mg·kg-1·h-1 in travenously. The depth of anesthesia was examined often by observing the effects of pressure to the paw on heart rate and blood pressure. The trachea was cannulated and each rat was mechanically ventilated with room air and supplemental oxy gen after immobilization by 5 to 10 mg/kg d-tubocurarine chlo ride. Catheters were placed in both femoral arteries: one for the measurement of systemic arterial pressure, and the other for withdrawing blood to change systemic arterial pressure and for sampling arterial blood. A femoral vein was cannulated for the infusion of drbgs. Rectal temperature was maintained at 37°C with a heating pad.
A craniotomy was prepared over the ventral brain stem as previously described in detail (Faraci et aI., 1987; Fujii et aI., 1991a; Toyoda et aI., 1996) . Portions of the dura and pia mater and the arachnoid membrane were resected. The open cranial window was suffused with artificial CSF (composition in mmollL: 132 NaCI, 2.95 KCI, 1.71 CaClz, 0.65 MgCI2, 24.6 NaHC03, and 3.69 D-glucose), warmed to 37°C, and continu ously bubbled with a gas mixture of 5% CO2 and 95% N2. Suffusion rate of CSF using inlet and outlet ports over the exposed brain stem was 3.0 mUmin. In CSF sampled from the craniotomies, Pe02 was 37.2 ± 3.0 mm Hg, P02 was 117 ± 15 mm Hg and pH was 7.41 ± 0.04 (mean ± SD). The diameters of the basilar artery, a large branch directly originating from the basilar artery with a baseline diameter �80 fLm and a small one with a baseline diameter <80 fLm were measured in each rat using a microscope equipped with a television camera coupled to a video monitor and a width analyzer (C3161, Hamamatsu Photonics, Hamamatsu, Japan). The images were recorded on videotape for later analyses.
Cerebral blood flow to the ventral brain stem was measured by laser-Doppler flowmetry (ALF 21D Model, Advance Co. Ltd., Tokyo, Japan) equipped with a 550-fLm-diameter needle probe as described previously (Fujii et aI., I 991b; Toyoda et aI., 1996) . Briefly, the probe was placed lateral to, but near the basilar artery in the cranial window and advanced into the CSF approximately 0.2 mm above the surface of the brain stem. We regarded laser-Doppler flowmetry outputs as arbitrary units and expressed changes in CBF as a percentage of the baseline CBF.
Experimental protocol
Four treatment groups and a control group of animals were studied. Topical application of 10-5 mollL L-NNA (n = 9), 10-4 mollL L-NNA (n = 9), 10-5 mollL 7-NI (n = 8), or 10-7 J Cereb Blood Flow Metab, Vol. J 7. No. 10. J 997 mollL serotonin (n = 8) as a NO-independent vasoconstrictor agonist was started after measurements of baseline diameters of the basilar artery and its branches along with CBF to the brain stem, and were continued through the whole experimental pe riod. In the control rats (n = 9), saline was topically applied. The drugs or saline were mixed in artificial CSF and superfused over the craniotomy. Stepwise hypotension, approximately 15 mm Hg per step, was induced by controlled withdrawal of blood through the femoral arterial cannula 60 minutes after topical application of the drugs was started. It is considered that 60 minutes was enough for the drugs to inhibit NOS in the cortex (Irikura et aI., 1994; Ngai et aI., 1995) . We maintained mean arterial blood pressure (MABP) at each step for approxi mately 4 minutes and measured vessel diameter and CBF dur ing the last minute, because these parameters were usually stable within last 2 minutes. Arterial blood gases, hematocrit, and blood glucose levels were determined twice during hypo tension, at the MABP of 60 mm Hg and 30 mm Hg, as well as before hypotension.
Responses of the basilar artery and its branches to 10-5 mollL acetylcholine and 10-7 moUL sodium nitroprusside were examined at baseline and during topical application of drugs before hypotension as well as at the MABP of 30 mm Hg in each group.
Statistical analysis
Values are expressed as means ± SD. One-way repeated measures analysis of variance (ANOVA) followed by Fisher's PLSD test for significance was used for the comparison of stepwise CBF and vasodilator responses with the baseline value within a group. One-way factorial ANOV A followed by Fish er's PLSD test was used for the comparison of the responses among groups. Two-way repeated-measures ANOV A followed by Fisher's PLSD test was used for the comparison of whole MABP-response curves of vasodilation among groups. P < 0.05 was accepted as statistically significant.
RESULTS
Baseline physiological variables were within normal limits and similar among groups (Table 1) . Topical ap plication of drugs had no effect on systemic arterial blood pressure. Arterial Pco2 and hematocrit levels de creased significantly and similarly at 30 mm Hg in all groups, whereas P02 and glucose significantly increased at 30 mm Hg in some groups.
Effects of L-NNA and 7-NI on CBF and its changes during hypotension
Topical application of saline in the control group had no effect on CBF (0 ± 4% from the baseline value). Topical application of L-NNA significantly decreased CBF (-11 ± 13% in 10-5 mollL L-NNA group, -11 ± 11 % in 10-4 mollL L-NNA group). 7-nitro indazole and serotonin did not alter CBF (l ± 16% in 7-NI group and -3 ± 3% in serotonin group).
In the control group, CBF was well maintained until MABP was reduced to 45 mm Hg and decreased signifi cantly thereafter ( Fig. 1) . CBF started to decrease sig nificantly at 45 mm Hg in the 10-5 moUL L-NNA group, and at 60 mm Hg in the 10-4 moUL L-NNA group, with steeper reduction of CBF thereafter in the 10-4 mol/L L-NNA group. In 7-NI and serotonin groups, CBF de creased significantly at 30 mm Hg and below. Thus, the lower limit of CBF autoregulation was 30 to 45 mm Hg in the control, 7-Nl, and serotonin groups, 45 to 60 mm Hg in the 10-5 mollL L-NNA group, and 60 to 75 mm Hg in the 10-4 mollL L-NNA group. 
Effects of L-NNA and 7-NI on basal vessel diameter and on vascular responses to agonists
Baseline diameter of vessels did not differ among the five groups (Table 2) . Topical application of L-NNA and serotonin significantly decreased diameter of all-sized vessels. In contrast, 7-NT had no significant effects on vessel diameters. Topical application of 10-5 mollL acetylcholine induced dilatation in all-sized vessels, and the response was almost completely abolished by either 10-5 mollL or 10-4 mollL L-NNA. 7-nitro indazole and serotonin had no effects on responses to acetyl choline in any-sized vessels. Responses of vessels to sodium nitroprusside, indicating its dilator reserve, were well preserved during each drug application (both at resting MABP or at 30 mm Hg), and these responses were much larger in L-NNA groups than the other groups.
Effects of L-NNA and 7-NI on changes in vessel diameter during hypotension
Tn the control group, diameter of the basilar artery was essentially constant until MABP reached 60 mm Hg, and it dilated significantly at 45 mm Hg and below with maximum dilatation at 30 mm Hg (Fig. 2) . In the L-NNA groups, dilatation of the basilar artery during severe hy potension (�45 mm Hg) was attenuated, and it was sig nificant only at 30 and 15 mm Hg. In the 7-NI group, the basilar artery dilated significantly at a higher level of MABP (60 mm Hg) compared with the control group. In the serotonin group, the basilar artery dilated signifi cantly at 45 mm Hg and below. The dilatation at 30 mm Hg was 34 ± 11 % in the control group, 16 ± 24% in the 10-5 moUL L-NNA group, 12 ± 13% in the 10-4 mollL L-NNA group, 31 ± 9% in the 7-NI group, and 22 ± 12% in the serotonin group, with significant difference be tween the control group and each L-NNA group (P < 0.05). Changes in the diameter through stepwise hypo tension were significantly different between the control and the 10-4 moUL L-NNA groups (P < 0.05, two-way repeated-measures ANOV A). The dilatation of the large branch reached the statisti cal significance at 45 mm Hg for the control and 10-4 moUL L-NNA groups, 60 mm Hg for the 10-5 moUL L-NNA group, and 75 mm Hg for the 7-NI and serotonin groups (Fig. 3) . Changes in the diameter of the large branch through stepwise hypotension, as well as its maximum change at 30 mm Hg, did not differ signifi cantly among the groups. Response of the small branch during hypotension showed essentially the same findings as those of the large branch (Fig. 4) . 
DISCUSSION
There are three major findings in the present study. First, during inhibition of NOS by topical application of L-NNA, CBF to the brain stem started to decrease at higher steps of MABP in stepwise hypotension than dur ing topical application of saline or serotonin, another vasoconstrictor agent. Alternatively, inhibition of NOS shifted the endpoint of CBF autoregulatory plateau in the brain stem upward in a concentration-dependent manner. Second, the inhibition of NOS by L-NNA attenuated di lator responses of the basilar artery but not those of the branches during severe hypotension. Third, the selective inhibition of neuronal NOS by topical application of 7-NI did not affect changes in CBF throughout the entire pressure range. Thus, NO seems to mediate, at least in part, CBF autoregulation in the brain stem and dilator responses of the basilar artery in hypotension around the lower limit of the autoregulation. Nitric oxide production during hypotension may be achieved by an activation of endothelial but not neuronal NOS.
Comparison with previous studies
The role of NO in CBF autoregulation is conflicting (Wang et aI., 1992b; Buchanan and Phillis, 1993; Tanaka et aI., 1993; Kelly et aI., 1994; Kobari et aI., 1994; Ta kahashi et aI., 1995) . Majority of previous studies showed that, although NOS inhibitors reduced the basal CBF, they did not affect CBF autoregulation during hy potension (Wang et aI., 1992b; Buchanan and Phillis, 1993; Takahashi et aI., 1995) . In contrast, others showed that NO contributes to maintenance of CBF during mild hypotension of 30 to 40 mm Hg below the baseline blood pressure (Tanaka et aI., 1993; Kobari et aI., 1994) . The present study agrees in part with the latter findings in that NOS inhibitors impair CBF autoregulation. However, our results are unique in that autoregulation was im paired principally during profound hypotension and not during mild hypotension. Recently, Huang et a1 . (1996) reported that endothelial NOS mutant mice showed sig nificant decreases in parietal CBF measured by laser Doppler flowmetry during severe hemorrhagic hypoten sion around 20 to 30 mm Hg compared with the wild type strain, which strongly supports our findings that NO plays a major role in autoregulation under profound hy potensive condition. Discrepancies of the results between our studies and the previous ones may partly result from the differences of the sorts and routes of administration of NOS inhibitors, brain regions, and severity of hypo tension. In some previous studies, forebrain CBF was usually measured under systemic application of N monomethyl L-arginine or nitro-L-arginine methyl ester where systemic effects of the drugs could not be ruled out. Some of the previous conclusions were obtained from only one or a few steps of hypotension.
We consider that the present methods have some ad vantages over previous ones. They are as follows: main taining the resting systemic blood pressure by topical application of drugs; simultaneous observation of changes in CBF and diameters of different-sized vessels; and continuous observation of the changes throughout the pressure changes (Faraci et aI., 1987; Fujii et aI., 1991a; Toyoda et aI., 1996) .
Nitric oxide and the basilar artery
Nitric oxide contributes to the regulation of vascular tone of the large cerebral arteries under resting condi tions and in response to diverse vasoactive stimuli (Faraci, 1990; Wang et aI., 1992a; Buchanan and Phillis, 1993; Pelligrino et aI., 1993) . Regarding the basilar ar tery, topical application of NOS inhibitors produces con centration-dependent constriction under resting condi tions and attenuates its dilator response to acetylcholine (Faraci, 1990) . In the present study, L-NNA induced sig nificant constriction of the basilar artery along with sig nificant reduction in CBF, although the decrease in CBF was much smaller than that in diameter.
The present study showed a characteristic change in CBF; L-NNA preserved CBF plateau during mild hypo tension and induced upward shift of the endpoint of CBF autoregulatory plateau, the traditional lower limit of CBF autoregulation. This pattern suggests that NO works as a regulator of CBF mainly during severe hypotension around the lower limits. Our previous study showed that the basilar artery also actively dilated and served as re sistance vessels in this pressure range (Toyoda et a!., 1996) . Thus, attenuation of the dilatation of the basilar artery by L-NNA may explain the decrease in CBF dur ing severe hypotension. We can exclude the possibility that L-NNA produces nonspecific impairment of dilator responses of the basilar artery, because its response to sodium nitroprusside was not inhibited by L-NNA.
Serotonin, another potent vasoconstrictor agent, tended to decrease the dilatation of the basilar artery during hypotension. However, this attenuation was smaller than that in L-NNA groups, and the significant dilatation of the basilar artery during hypotension was observed at the same level of MABP as the control group. In ad�ition, changes in CBF during hypotension in the serotonin group were virtually the same as those in the control group. Thus, we consider that vasoconstric tion produced by NOS inhibition did not play a major role in the impairment of vasodilation and CBF auto regulation during hypotension, and inhibition of NO pro duction per se was primarily responsible for the impair ment.
In this study, we did not clarify the mechanisms that activate NOS despite blood pressure changes. Hypoxia seems to be a dominant mechanism involved in hypo tension-induced cerebral vasodilatation (Kontos et a!., 1978b) , and inhibition of NOS attenuates cerebral vaso dilation (Pelligrino et aI., 1995) and increases in CBF (Iwamoto et aI., 1992) during severe hypoxia. Thus, local hypoxia may be an important trigger of activation of NOS under hypotensive conditions. It has been well known that increased shear stress and stretch forces ex erted on endothelial cells by blood flow and pressure stimulate NO release (Cooke et aI., 1990) . Severe hem orrhagic hypotension decreases shear stress and stretch forces, and therefore may attenuate endothelial NO re lease in each group. If this were true, we would see the diminished effect of NOS inhibition during hypotension.
Nitric oxide and the small arteries
Responses to NOS inhibitors are dependent on the size of cerebral vessels, i.e. topical application of N monomethyl L-arginine produced significantly larger constriction in the basilar artery than in its branches or J Cereh Blood Flow Metah. Vol. 17 , No. 10 , 1997 parietal arterioles (Faraci, 1991) . Basal production of NO may be greater in the large arteries than in the microves sels, Several studies proved the minor contribution of NOS to microcirculation (Marshall et aI., 1988; Miigge et aI., 1991) .
The present study showed that, while L-NNA reduces the resting diameter of any-sized branches as much as the basilar artery, it did not attenuate the dilatation of the branches in response to hypotension which contrasts to the finding in the basilar artery. This finding suggests that mechanisms independent of NOS are primarily re sponsible for dilatation of the small arteries during hy potension. Using the present technique, we cannot di rectly observe penetrating arterioles, presumed major sites for CBF autoregulation. We consider, however, that these arterioles actively dilate and contribute to mainte nance of CBF to the brain stem during mild hypotension, because autoregulatory plateau of CBF in this pressure range was preserved in L-NNA groups without vasodi lator compensation of the basilar artery and its branches. Thus, NO may not be a major regulator of vascular tone of the small arterioles, whether superficial or deep, dur ing hypotension.
Neuronal nitric oxide synthase for CBF autoregulation Endothelial and neuronal NO may be involved in CBF autoregulation in a different manner. Huang et al. (1996) reported the impaired autoregulatory plateau of parietal CBF in endothelial NOS mutant mice, and suggested the contribution of endothelial NO to CBF autoregulation. In the contrast, some studies suggest that neuronal NO has a potential to regulate CBF (Kelly et aI., 1995; Wang et aI., 1995) . Systemic injection of 7-NI caused significant reduction of both basal CBF and the response to hyper capnia, along with reduction of brain NOS activity and preservation of endothelial NOS-induced vasodilation.
In the present study, we topically applied a tenfold higher concentration of ICso of 7-NI, which caused an approximate 80% reduction of rat cerebellar NOS activ ity in vitro (Babbedge et aI., 1993) . This inhibitor did not affect basal CBF, baseline diameter of any vessels, or vasodilator response to acetylcholine. During mild hy potension, autoregulatory plateau of CBF was preserved and dilator responses of each-sized vessels were some what augmented in 7-NI-treated rats. During severe hy potension around the lower limit of CBF autoregulation, 7-NI had no significant effects on reduction of CBF or dilatation of the vessels. These results do not support the positive contribution of neuronal NOS to the regulation of CBF during hypotension. Even the topical application of a higher concentration of 7-NI (10-4 mollL) did not affect either basal CBF or CBF autoregulation during hypotension, accompanied by an increase in the basal vessel diameter (12% in the basilar aIiery) and ex agger-ated vasodilation during mild hypotension (14% at 60 mm Hg in the basilar artery) (unpublished observation).
An in vitro study also demonstrated that 7-NI induced an unusual relaxation of the middle cerebral artery in dogs irrespective of presence of functional endothelium or pretreatment by nonselective NOS inhibitor, which sug gested direct vasodilator actions of 7-NI (Medhurst et aI., 1994) . Thus, augmentation of the vasodilator responses during mild hypotension may partly support the effec tiveness of 7-NI in this study.
The difference in the route of 7-NI administration may result in the disparate change in basal CBF between our study and previous ones. Our previous study using the same window technique showed that superfusion of va sopressin, having much higher molecular weight (F.W. 1084.2) than L-NNA (F.W. 219.2) or 7-NI (F.W. 163.14), effectively reduced CBF (Fujii et aI., 199Ib) . This finding suggests that topically applied drugs are able to reach arterioles in small volumes of brain tissue (approximately I mm } ) of which blood flow is measured by laser-Doppler flowmetry. However, we could not pro vide decisive evidence to support the effectiveness of 7-NI in our in vivo preparation in which the drug was administered topically through the cranial window. Thus, we cannot exclude the possibility that 7-NI had no effect because of {nappropriate conditions.
Another mechanism for CBF autoregulation
We recently clarified using the same window tech nique that inhibition of opening of A TP-sensitive potas sium channels by topical application of glibenclamide impaired the dilator response of rat brain stem arterioles with a baseline diameter <70 f.1m during hypotension and shifted the lower limit of CBF autoregulation upward (Toyoda et aI., 1997) . In contrast, glibenclamide did not attenuate the dilatation of the basilar artery during hypo tension. Thus, different factors seem to contribute to the autoregulatory responses of brain stem vessels with dif ferent size, i.e., endothelial NO regulates the tone of large arteries and ATP-sensitive potassium channels regulate microcirculation. Kontos and Wei (1996) re cently reported that L-arginine analogues like L-NNA can inhibit opening of ATP-sensitive potassium channels as well as NOS. However, considering above findings to gether, the inhibitory effect of L-NN A on dilatation of the basilar artery observed in the present study does not seem to be caused by blockade of ATP-sensitive potas sium channels but seems to be caused by its action on NOS.
In conclusion, endothelial NO plays a significant role in the autoregulatory response of large arteries and thus maintaining CBF to the brain stem during severe hypo tension around the lower limit of CBF autoregulation. However, NO does not seem to mediate the response during mild hypotension within the autoregulatory pla teau of CBF.
